ACME GROUP of companies are professionally managed pharmaceutical companies, manufacturing wide range of Human Medicinal formulations like Small Volume Parenterals, Tablets, Oral Powders in Sachets,ORS, Artificial & Natural Sweeteners as well as Veterinary Boluses and Powders. The company was incorporated in the year 1985. The group companies are actively involved in the field of contract manufacturing since almost last three decades.
Details of Manufacturing Facilities:
1. ACME PHARMACEUTICALS PVT. LTD - Manuacturer of General Liquid Injectables in Glass Ampoules & Vials
(WHO GMP & PPB-Kenya Approved)
Site Address : PF 61&62, sanand II industrial area, GIDC, Sanand, Dist. Ahmedabad, Gujarat, India
Registratrion in process: Ethiopia-FMHACA, Nigeria-NAFDAC, Philippines FDA, MoH Yemen, MoH IRAQ/KMCA., TFDA-Tanzania, NDA-Uganda etc.Future Target: PICS & EU GMP
Kindly view video presentation from this link:
2. ACME LIFE TECH-LLP (WHO GMP approved) Plot no. 103,104,105 epip phase I,Jharmajri, baddi, H.P., India
Registratrion in process: Philippines , Yemen,Nigeria, PANAMA, CAMBODIA, MYANMAR, UZBEKISTAN, TAJIKISTAN, BELARUS, GUATEMALA etc.
Future Target: PICS & EU GMP
3. ACME DIET CARE PVT. LTD - ORS & Food Products
(WHO GMP , ISO and HACCP Approved) 14, Panchratna Industrial Estate, Changodar, Dist. Ahmedabad
4. SHANKU'S PHARMACEUTICALS - APIs & Advanced Intermediate Products
(WHO GMP Approved), Plot No 9, 10, 11 Milan Industrial Estate, Vadsar Road, Santej, Ta: Kalol,Dist: Gandhinagar - 382721, Gujarat, India.
Shanku's Pharmaceuticals is for a decade, engaged in manufacture and research based at Ahmedabad. Our portfolio includes APIs and Advanced
intermediates, duly supported by in-house R&D team.
Established in 2002, Aurisco is an innovative company dedicated to developing and manufacturing pharmaceutical chemicals serving pharmaceutical companies worldwide. The head office is in Shanghai. Three production facilities & 3 R&D centers are separately based in Zhejiang Tiantai & Jiangsu Yangzhou. Aurisco is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality-minded production. Creative thinking, dedicated staff and sound resources are the strengths that Aurisco relies on for further growth.
Beijing Infoark Co Ltd, established in 1997, specializes in pharmaceuticals, intermediates, food and feed additives, veterinary, health and nutrition products. After years of rapid development, Infoark has become one of the largest and most professional suppliers in China, and grows to be an integrated company covering R&D, production and sales, with international trade as the main development direction based upon the leading high-tech R&D and production site.
Biophore, an established pharmaceutical company is engaged in the development and manufacture of niche pharmaceutical products for generic industry.Within a decade since inception in 2007, Biophore has emerged as a trusted partner in generic industry across US, Europe and other regulated markets. Biophore's product range is diverse and balanced with NCE, Branded products and grandfather products.
Biophore's portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media.
For updated list of products, send an email to email@example.com
Brooks Laboratories Ltd was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company. In last 6 years company has successfully established itself as a reputed Contract Manufacturing company for generic products in Injectables and Amoxiillin + Clavulanic Acid range of Tablets and Dry Syrups. Brooks has recently commissioned a Brand New Dedicated Facility for Carbapenem Injections at Baroda, India, with a huge capacity of 50 million vials per annum. The New Carbapenem Facility at Baroda will also manufacture Lyophilized Carbapenem injections like Ertapenem. The new Dedicated Carbapenem Plant has been designed for Development and Supply of Injections for Europe, USA, Canada, Australia, South Africa and other Regulated Markets and also do Contract Manufacturing for Quality Conscious Pharmaceutical companies for Regulated and Semi Regulated Markets. Brooks can as well provide interested customers with ANDAs and Dossiers in CTD formats. The new Plant at Baroda has good capacity to cater to big markets of USA, Europe etc. The entire new plant of Carbapenems at Baroda has been designed as per the cGMP requirements of US-FDA, European GMP standards and WHO standards. The Carbapenem plant is scheduled for a European GMP audit and certification in August '2017. Interested parties for Carbapenems and other injections can contact us - firstname.lastname@example.org
Lee harma Limited has been established in 1997 in India. We manufacture several intermediate chemicals, Active Pharmaceutical Ingredients & Semi-finished Dosage Forms like Pellets, Mups, Sachets & Granules and Finished Formulations. Our expertise in the field won us numerous clients in India as well as across the globe.
Lee Pharma Manufacturing facilities are approved by several international regulatory bodies such as USFDA, EUGMP, WHO GMP etc.
Lee Pharma manufactureres and exports bulk drugs and semi finished formulations like anti-hypertensives, anti-ulcertatives, anti-diabetic, anti-fungals, anti-platelet, hyper lipidemic/HMG reductase inhibitor, Anti-Coagluant, anti-depressants, anti-psychotic, anti-convulsant, anti-histamine, anti-osteoporosis, smoking cessation, anti-obesity, benign prostatic hypertrophy drugs Active Pharmaceutical Ingredients (APIs) and its advanced intermediates, pellets, etc
Morepen Laboratories Limited is a 33 year old company manufacturing APIs (Loratadine, Desloratadine, Atorvastatin, Montelukast, Rosuvastatin, Fexofenadine, Olmesartan, Sitagliptin Linagliptin, Saxagliptin, Dapagliflozin, Canagliflozin etc.) at its world class manufacturing facilities, approved by USFDA, European & other regulatory authorities. Morepen adheres to latest cGMP standards, has DMF/CoS/Tech.Packs, exports to more than 60 countries.
Nutra is a pioneer manufacturer of unique niche APIs and have 3 COS Approval, 1 MHRA Approval and 2 Korean FDA Approvals. We are also simultaneously working on USFDA, ANVISA and Chinese SFDA for our key product Olmesartan Medoxomil. We are leaders in Warfarin Sodium, Tetracaine HCL and Olmesartan along with upcoming gliptin molecules. We have WHO GMP and ISO 9001:2008 certification and focus on stringent quality standards and continously upgrade our manufacturing technology to upkeep the competitive industry. We have crossed a revenue of USD 15Mn and have over 160 Employees and are aiming to be Leading Niche Manufacturer.
After 30 years growth, langhua has been the
leading company of Quinolones, Anti-virus, Cardiovascular and Anti-depressant
APIs and intermediates. Based on cGMP & ICH guideline, Langhua established
good quality system and passed US-FDA, WHO, EDQM, ANVISA and CFDA's on-site inspections.
Langhua's vision is to be the customer-preferred APIs manufacturer and valuable CDMO partner. Driven by reliability, flexibility, efficiency and innovation, Langhua focuses on medicine's availability and affordability.
With high GMP and EHS compliance. ISO 14001 and OHSAS 18001 certificates be obtained.